SGLT2 抑制剂减弱了胆固醇在人类大动脉光滑肌细胞中的积累
Agnieszka Pawlos1, Ewelina Woźniak1, Marlena Broncel1
1Department of Internal Diseases and Clinical Pharmacology, Lipid Disorders Treatment Center, Laboratory of Tissue Immunopharmacology, Medical University of Lodz, Lodz, Poland.
Advances in medical sciences
|November 2, 2025
概括
-葡萄糖共运输体2 (SGLT2) 抑制剂可以减少胆固醇在人类大动脉光滑肌细胞中的积累. 这些发现表明,SGLT2抑制剂可能对这些细胞中胆固醇积累产生保护作用.
科学领域:
- 心血管药理学心血管药理学
- 细胞生物学 细胞生物学
- 代谢性疾病研究研究
背景情况:
- 人类大动脉光滑肌细胞 (HAoSMC) 中的胆固醇积累有助于动脉样硬化.
- -葡萄糖共载体2 (SGLT2) 抑制剂对细胞胆固醇水平的影响在很大程度上仍未被探索.
研究的目的:
- 研究SGLT2抑制剂对HAoSMC中的胆固醇积累的影响.
- 评估SGLT2抑制剂对血管细胞中脂质沉积的潜在保护机制.
主要方法:
- 用不同度的empagliflozin,dapagliflozin和canagliflozin来治疗HAoSMCs.
- 细胞被暴露在胆固醇-甲基-β-环极胺复合物中,以诱导脂质积累.
- 油红色O染色量化脂质含量,吸收度测在492nm.
主要成果:
- 胆固醇复合物显著增加了HAoSMC中的脂质积累 (31.8%).
- SGLT2 抑制剂显著降低了胆固醇诱导的脂质积累 (9.818.2%).
- 恩帕格利弗洛辛和达帕格利弗洛辛在两种测试度上都表现出显著的影响,而卡纳格利弗洛辛仅在较高度时显著.
结论:
- 在HAoSMC中,SGLT2抑制剂显示出对胆固醇积累的潜在保护作用.
- 在SGLT2抑制剂中,疗效略有差异,empagliflozin和dapagliflozin显示一致的效果.
- 这些发现可能对治疗SGLT2抑制剂的患者的血管并发症的管理产生影响.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
Atherosclerosis III: Management
311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
Antihypertensive Drugs: Action of Calcium Channel Blockers
1.5K
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.5K
Atherosclerosis I: Introduction
868
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
868
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K


